Abstract
To the Editor: —One out of every five men over 50 years of age has carcinoma of the prostate. The growth of carcinoma of the prostate is stimulated by testosterone. Does more need to be said? Do we need to undertake a detailed consideration of the advisability of giving men over 50 a medicament that is possibly, probably, or potentially harmful to 20% of them? Apparently, the answer is yes. Four times in this past week we have received advertising folders from pharmaceutical firms highly recommending that we so prescribe for our patients. Testosterone has been advocated for some time for a rather vague group of conditions in older men, and recently there has been a wave of enthusiasm for a combination of androgenic and estrogenic substances presumed to provide a "balanced" hormonal therapy especially beneficial in geriatric practice. Concerning estrogens, it seems fair to say that the administration of
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
